Cargando…
Current status and future perspectives of HLA-edited induced pluripotent stem cells
In 2007, Human-induced pluripotent stem cells (iPSCs) were generated by transducing four genes (Oct3/4, Sox2, Klf4, c-Myc). Because iPSCs can differentiate into any types of cells in the body and have fewer ethical issues compared to embryonic stem (ES) cells, application of iPSCs for regenerative m...
Autores principales: | Koga, Keiko, Wang, Bo, Kaneko, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528263/ https://www.ncbi.nlm.nih.gov/pubmed/33014207 http://dx.doi.org/10.1186/s41232-020-00132-9 |
Ejemplares similares
-
Induced Pluripotent Stem Cells: Current Progress and Future Perspectives
por: Zhou, Qi
Publicado: (2013) -
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives
por: Chun, Yong Soon, et al.
Publicado: (2011) -
Induced pluripotent stem cells in hematology: current and future applications
por: Focosi, D, et al.
Publicado: (2014) -
Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
por: Singh, Ratnesh, et al.
Publicado: (2018) -
CRISPR/Cas Genome Editing in Potato: Current Status and Future Perspectives
por: Tiwari, Jagesh Kumar, et al.
Publicado: (2022)